Spontaneous Degenerative Aortic Valve Disease in New Zealand Obese Mice.
Ott C, Pappritz K, Hegemann N, John C, Jeuthe S, McAlpine CS, Iwamoto Y, Lauryn JH, Klages J, Klopfleisch R, Van Linthout S, Swirski F, Nahrendorf M, Kintscher U, Grune T, Kuebler WM, Grune J.
J Am Heart Assoc. 2021 Dec 7;10(23):e023131. doi: 10.1161/JAHA.121.023131. Epub 2021 Nov 15.
Thoracic Aortic Aneurysm: A Clinical Review.
Senser EM, Misra S, Henkin S.
Cardiol Clin. 2021 Nov;39(4):505-515. doi: 10.1016/j.ccl.2021.06.003.
Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, Alahdab F, Alashi A, Alipour V, Arabloo J, Azari S, Barthelemy CM, Benziger CP, Berman AE, Bijani A, Carrero JJ, Carvalho F, Daryani A, Durães AR, Esteghamati A, Farid TA, Farzadfar F, Fernandes E, Filip I, Gad MM, Hamidi S, Hay SI, Ilesanmi OS, Naghibi Irvani SS, Jürisson M, Kasaeian A, Kengne AP, Khan AR, Kisa A, Kisa S, Kolte D, Manafi N, Manafi A, Mensah GA, Mirrakhimov EM, Mohammad Y, Mokdad AH, Negoi RI, Thi Nguyen HL, Nguyen TH, Nixon MR, Otto CM, Patel S, Pilgrim T, Radfar A, Rawaf DL, Rawaf S, Rawasia WF, Rezapour A, Roever L, Saad AM, Saadatagah S, Senthilkumaran S, Sliwa K, Tesfay BE, Tran BX, Ullah I, Vaduganathan M, Vasankari TJ, Wolfe CDA, Yonemoto N, Roth GA; Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators.
Circulation. 2020 May 26;141(21):1670-1680. doi: 10.1161/CIRCULATIONAHA.119.043391. Epub 2020 Mar 29.
Surgery for asymptomatic degenerative aortic and mitral valve disease.
Vaishnava P, Fuster V, Goldman M, Bonow RO.
Nat Rev Cardiol. 2011 Mar;8(3):173-7. doi: 10.1038/nrcardio.2010.203. Epub 2011 Jan 18.
Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.
Nazarzadeh M, Pinho-Gomes AC, Bidel Z, Dehghan A, Canoy D, Hassaine A, Ayala Solares JR, Salimi-Khorshidi G, Smith GD, Otto CM, Rahimi K.
Eur Heart J. 2020 Oct 21;41(40):3913-3920. doi: 10.1093/eurheartj/ehaa070.
Dyslipidemia and aortic valve disease.
Mata P, Alonso R, Pérez de Isla L, Badimón L.
Curr Opin Lipidol. 2021 Dec 1;32(6):349-354. doi: 10.1097/MOL.0000000000000794.
Impact of osteogenic activity on degenerative aortic valve disease in patients with osteoporotic hip fracture.
Furugen M, Watanabe N, Nishino S, Kimura T, Ashikaga K, Kuriyama N, Shibata Y.
J Cardiol. 2021 Nov;78(5):423-430. doi: 10.1016/j.jjcc.2021.05.014. Epub 2021 Jun 12.
Sarcopenia and aortic valve disease.
Kumar M, Pettinato A, Ladha F, Earp JE, Jain V, Patil S, Engelman DT, Robinson PF, Moumneh MB, Goyal P, Damluji AA.
Heart. 2024 Jul 10;110(15):974-979. doi: 10.1136/heartjnl-2024-324029.
Aortic valve repair update.
Komiya T.
Gen Thorac Cardiovasc Surg. 2015 Jun;63(6):309-19. doi: 10.1007/s11748-015-0523-1. Epub 2015 Feb 5.
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities.
Pinto G, Fragasso G.
Expert Opin Ther Targets. 2022 Jul;26(7):633-644. doi: 10.1080/14728222.2022.2118576. Epub 2022 Sep 6.
